Thus our comprehensive analyses establishes that the downregulation of SEMA3B and its coreceptor NRP1 manifests at both the transcriptional and protein levels within the lungs and fibroblasts of IPF patients. Here, NRP1 is linked to idiopathic pulmonary fibrosis.